Cargando…
Targeting the 4-1BB costimulatory molecule through single chain antibodies promotes the human T-cell response
BACKGROUND: Adoptive T-cell therapy (ACT) using autologous tumor-reactive T lymphocytes has considerable potential for cancer immunotherapy. In ACT, T cells are isolated from cancer patients and then stimulated and expanded in vitro by cytokines and costimulatory molecules. 4-1BB is an important cos...
Autores principales: | Bagheri, Salman, Safaie Qamsari, Elmira, Yousefi, Mehdi, Riazi-Rad, Farhad, Sharifzadeh, Zahra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178758/ https://www.ncbi.nlm.nih.gov/pubmed/32336974 http://dx.doi.org/10.1186/s11658-020-00219-8 |
Ejemplares similares
-
Development of a human phage display-derived anti-PD-1 scFv antibody: an attractive tool for immune checkpoint therapy
por: Ghaderi, Sepideh Safaei, et al.
Publicado: (2022) -
Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations
Publicado: (1992) -
Neuroimmune semaphorins as costimulatory molecules and beyond
por: Chapoval, Svetlana P.
Publicado: (2018) -
Altered expression of costimulatory molecules in dementias
por: Busse, Stefan, et al.
Publicado: (2021) -
New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis
por: Etxeberria, Iñaki, et al.
Publicado: (2020)